Companies › ALMS

ALUMIS INC (ALMS)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001847367 · EDGAR filings · Updated 2026-07-27

ALUMIS INC (ALMS) has reported institutional ownership of 79.5%, with 196 institutional managers holding positions valued at $2.19B per the latest 13F reporting period. SEC filings include an active substantial-doubt (going concern) disclosure per the filings.

Filings this week (1)

• 2026-07-27 — SCHEDULE 13G filed

Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.

Latest updates

• 2026-07-08 — Insider transaction reported (Form 4)
• 2026-07-06 — Notice of proposed sale filed (Form 144)
• 2026-07-02 — Insider transaction reported (Form 4)
• 2026-07-02 — Insider transaction reported (Form 4)
• 2026-07-02 — Insider transaction reported (Form 4)

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, ALUMIS INC has 196 institutional holders and institutional ownership of 79.5%.

Insider activity

Insiders reported 59 transactions (48 buys, 0 sells) across 18 reporting insiders, with a net reported value of $53.3M.

Data flags from SEC filings

Related companies

SAREPTA THERAPEUTICS INC (SRPT) · VIRIDIAN THERAPEUTICS INC (VRDN) · KODIAK SCIENCES (KOD) · KINIKSA PHARMACEUTICALS INTL (KNSA) · NEOGEN CORPORATION (NEOG) · AGIOS PHARMACEUTICALS INC (AGIO)